Datasets:
Season
stringclasses 3
values | Week
int64 202k
202k
| Virus
stringclasses 3
values | Region
stringclasses 11
values | Age Group
stringclasses 7
values | Number Positive
int64 0
6.5k
| Number Tested
int64 0
12.9k
| Percent Positive
float64 0
100
|
---|---|---|---|---|---|---|---|
2021-22 | 202,147 | SARS-CoV-2 | Region 2 | 0-4 years | 0 | 7 | 0 |
2021-22 | 202,147 | SARS-CoV-2 | Region 2 | 5-17 years | 0 | 6 | 0 |
2021-22 | 202,147 | SARS-CoV-2 | Region 2 | 18-24 years | 2 | 24 | 8.33 |
2021-22 | 202,147 | SARS-CoV-2 | Region 2 | 25-49 years | 22 | 125 | 17.6 |
2021-22 | 202,147 | SARS-CoV-2 | Region 2 | 50-64 years | 32 | 104 | 30.77 |
2021-22 | 202,147 | SARS-CoV-2 | Region 2 | 65+ years | 19 | 100 | 19 |
2021-22 | 202,147 | SARS-CoV-2 | Region 3 | 0-4 years | 13 | 67 | 19.4 |
2021-22 | 202,147 | SARS-CoV-2 | Region 3 | 5-17 years | 9 | 28 | 32.14 |
2021-22 | 202,147 | SARS-CoV-2 | Region 3 | 18-24 years | 2 | 16 | 12.5 |
2021-22 | 202,147 | SARS-CoV-2 | Region 3 | 25-49 years | 18 | 56 | 32.14 |
2021-22 | 202,147 | SARS-CoV-2 | Region 3 | 50-64 years | 24 | 68 | 35.29 |
2021-22 | 202,147 | SARS-CoV-2 | Region 3 | 65+ years | 26 | 104 | 25 |
2021-22 | 202,147 | SARS-CoV-2 | Region 5 | 0-4 years | 0 | 1 | 0 |
2021-22 | 202,147 | SARS-CoV-2 | Region 5 | 5-17 years | 1 | 3 | 33.33 |
2021-22 | 202,147 | SARS-CoV-2 | Region 5 | 18-24 years | 5 | 16 | 31.25 |
2021-22 | 202,147 | SARS-CoV-2 | Region 5 | 25-49 years | 22 | 44 | 50 |
2021-22 | 202,147 | SARS-CoV-2 | Region 5 | 50-64 years | 15 | 32 | 46.88 |
2021-22 | 202,147 | SARS-CoV-2 | Region 5 | 65+ years | 13 | 31 | 41.94 |
2021-22 | 202,147 | SARS-CoV-2 | Region 6 | 0-4 years | 0 | 5 | 0 |
2021-22 | 202,147 | SARS-CoV-2 | Region 6 | 5-17 years | 1 | 2 | 50 |
2021-22 | 202,147 | SARS-CoV-2 | Region 6 | 18-24 years | 3 | 12 | 25 |
2021-22 | 202,147 | SARS-CoV-2 | Region 6 | 25-49 years | 11 | 59 | 18.64 |
2021-22 | 202,147 | SARS-CoV-2 | Region 6 | 50-64 years | 4 | 49 | 8.16 |
2021-22 | 202,147 | SARS-CoV-2 | Region 6 | 65+ years | 2 | 39 | 5.13 |
2021-22 | 202,147 | SARS-CoV-2 | Region 8 | 0-4 years | 42 | 681 | 6.17 |
2021-22 | 202,147 | SARS-CoV-2 | Region 8 | 5-17 years | 50 | 301 | 16.61 |
2021-22 | 202,147 | SARS-CoV-2 | Region 8 | 18-24 years | 46 | 203 | 22.66 |
2021-22 | 202,147 | SARS-CoV-2 | Region 8 | 25-49 years | 290 | 695 | 41.73 |
2021-22 | 202,147 | SARS-CoV-2 | Region 8 | 50-64 years | 152 | 416 | 36.54 |
2021-22 | 202,147 | SARS-CoV-2 | Region 8 | 65+ years | 213 | 623 | 34.19 |
2021-22 | 202,147 | SARS-CoV-2 | Region 9 | 0-4 years | 0 | 1 | 0 |
2021-22 | 202,147 | SARS-CoV-2 | Region 9 | 5-17 years | 0 | 0 | 0 |
2021-22 | 202,147 | SARS-CoV-2 | Region 9 | 18-24 years | 0 | 1 | 0 |
2021-22 | 202,147 | SARS-CoV-2 | Region 9 | 25-49 years | 0 | 2 | 0 |
2021-22 | 202,147 | SARS-CoV-2 | Region 9 | 50-64 years | 0 | 0 | 0 |
2021-22 | 202,147 | SARS-CoV-2 | Region 9 | 65+ years | 0 | 3 | 0 |
2021-22 | 202,147 | Influenza | Region 2 | 0-4 years | 0 | 7 | 0 |
2021-22 | 202,147 | Influenza | Region 2 | 5-17 years | 0 | 4 | 0 |
2021-22 | 202,147 | Influenza | Region 2 | 18-24 years | 5 | 17 | 29.41 |
2021-22 | 202,147 | Influenza | Region 2 | 25-49 years | 2 | 52 | 3.85 |
2021-22 | 202,147 | Influenza | Region 2 | 50-64 years | 0 | 49 | 0 |
2021-22 | 202,147 | Influenza | Region 2 | 65+ years | 0 | 58 | 0 |
2021-22 | 202,147 | Influenza | Region 3 | 0-4 years | 0 | 65 | 0 |
2021-22 | 202,147 | Influenza | Region 3 | 5-17 years | 0 | 22 | 0 |
2021-22 | 202,147 | Influenza | Region 3 | 18-24 years | 4 | 14 | 28.57 |
2021-22 | 202,147 | Influenza | Region 3 | 25-49 years | 2 | 35 | 5.71 |
2021-22 | 202,147 | Influenza | Region 3 | 50-64 years | 1 | 56 | 1.79 |
2021-22 | 202,147 | Influenza | Region 3 | 65+ years | 1 | 73 | 1.37 |
2021-22 | 202,147 | Influenza | Region 5 | 0-4 years | 0 | 0 | 0 |
2021-22 | 202,147 | Influenza | Region 5 | 5-17 years | 0 | 2 | 0 |
2021-22 | 202,147 | Influenza | Region 5 | 18-24 years | 0 | 7 | 0 |
2021-22 | 202,147 | Influenza | Region 5 | 25-49 years | 0 | 24 | 0 |
2021-22 | 202,147 | Influenza | Region 5 | 50-64 years | 0 | 13 | 0 |
2021-22 | 202,147 | Influenza | Region 5 | 65+ years | 0 | 14 | 0 |
2021-22 | 202,147 | Influenza | Region 6 | 0-4 years | 0 | 5 | 0 |
2021-22 | 202,147 | Influenza | Region 6 | 5-17 years | 0 | 2 | 0 |
2021-22 | 202,147 | Influenza | Region 6 | 18-24 years | 1 | 12 | 8.33 |
2021-22 | 202,147 | Influenza | Region 6 | 25-49 years | 1 | 59 | 1.69 |
2021-22 | 202,147 | Influenza | Region 6 | 50-64 years | 0 | 49 | 0 |
2021-22 | 202,147 | Influenza | Region 6 | 65+ years | 1 | 39 | 2.56 |
2021-22 | 202,147 | Influenza | Region 8 | 0-4 years | 2 | 655 | 0.31 |
2021-22 | 202,147 | Influenza | Region 8 | 5-17 years | 2 | 226 | 0.88 |
2021-22 | 202,147 | Influenza | Region 8 | 18-24 years | 5 | 105 | 4.76 |
2021-22 | 202,147 | Influenza | Region 8 | 25-49 years | 2 | 389 | 0.51 |
2021-22 | 202,147 | Influenza | Region 8 | 50-64 years | 2 | 287 | 0.7 |
2021-22 | 202,147 | Influenza | Region 8 | 65+ years | 1 | 443 | 0.23 |
2021-22 | 202,147 | Influenza | Region 9 | 0-4 years | 0 | 1 | 0 |
2021-22 | 202,147 | Influenza | Region 9 | 5-17 years | 0 | 0 | 0 |
2021-22 | 202,147 | Influenza | Region 9 | 18-24 years | 1 | 1 | 100 |
2021-22 | 202,147 | Influenza | Region 9 | 25-49 years | 0 | 2 | 0 |
2021-22 | 202,147 | Influenza | Region 9 | 50-64 years | 0 | 0 | 0 |
2021-22 | 202,147 | Influenza | Region 9 | 65+ years | 0 | 3 | 0 |
2021-22 | 202,147 | RSV | Region 2 | 0-4 years | 2 | 7 | 28.57 |
2021-22 | 202,147 | RSV | Region 2 | 5-17 years | 1 | 4 | 25 |
2021-22 | 202,147 | RSV | Region 2 | 18-24 years | 0 | 13 | 0 |
2021-22 | 202,147 | RSV | Region 2 | 25-49 years | 2 | 38 | 5.26 |
2021-22 | 202,147 | RSV | Region 2 | 50-64 years | 0 | 25 | 0 |
2021-22 | 202,147 | RSV | Region 2 | 65+ years | 3 | 26 | 11.54 |
2021-22 | 202,147 | RSV | Region 3 | 0-4 years | 14 | 50 | 28 |
2021-22 | 202,147 | RSV | Region 3 | 5-17 years | 3 | 18 | 16.67 |
2021-22 | 202,147 | RSV | Region 3 | 18-24 years | 0 | 10 | 0 |
2021-22 | 202,147 | RSV | Region 3 | 25-49 years | 0 | 22 | 0 |
2021-22 | 202,147 | RSV | Region 3 | 50-64 years | 0 | 38 | 0 |
2021-22 | 202,147 | RSV | Region 3 | 65+ years | 2 | 54 | 3.7 |
2021-22 | 202,147 | RSV | Region 5 | 0-4 years | 0 | 0 | 0 |
2021-22 | 202,147 | RSV | Region 5 | 5-17 years | 0 | 0 | 0 |
2021-22 | 202,147 | RSV | Region 5 | 18-24 years | 0 | 1 | 0 |
2021-22 | 202,147 | RSV | Region 5 | 25-49 years | 0 | 1 | 0 |
2021-22 | 202,147 | RSV | Region 5 | 50-64 years | 1 | 3 | 33.33 |
2021-22 | 202,147 | RSV | Region 5 | 65+ years | 0 | 6 | 0 |
2021-22 | 202,147 | RSV | Region 6 | 0-4 years | 2 | 5 | 40 |
2021-22 | 202,147 | RSV | Region 6 | 5-17 years | 0 | 2 | 0 |
2021-22 | 202,147 | RSV | Region 6 | 18-24 years | 1 | 12 | 8.33 |
2021-22 | 202,147 | RSV | Region 6 | 25-49 years | 0 | 59 | 0 |
2021-22 | 202,147 | RSV | Region 6 | 50-64 years | 1 | 49 | 2.04 |
2021-22 | 202,147 | RSV | Region 6 | 65+ years | 2 | 39 | 5.13 |
2021-22 | 202,147 | RSV | Region 8 | 0-4 years | 351 | 668 | 52.54 |
2021-22 | 202,147 | RSV | Region 8 | 5-17 years | 52 | 206 | 25.24 |
2021-22 | 202,147 | RSV | Region 8 | 18-24 years | 12 | 85 | 14.12 |
2021-22 | 202,147 | RSV | Region 8 | 25-49 years | 31 | 343 | 9.04 |
RESP-LENS
Description
During the 2022-23 and 2023-24 respiratory illness seasons, the Respiratory Virus Laboratory Emergency Department Network Surveillance (RESP-LENS) system gathered electronic health record (EHR) data from nearly 100 hospitals associated with 24 participating sites located in 20 states and the District of Columbia. There was at least one site in each of the 10 Health and Human Services (HHS) regions. RESP-LENS collected reports of emergency department (ED) visits for acute respiratory illness (ARI) and corresponding viral testing results for SARS-CoV-2 (the virus that causes COVID-19), influenza (flu), and respiratory syncytial virus (RSV). Sites reported data for an average of approximately 77,000 ED visits weekly, of which 11,000 were associated with ARI and 4,000 of those were in children younger than 18 years. Between May 2023 and August 2024, these data were posted to CDC's RESP-LENS public dashboard, showing number tested, number positive, and percent positive for each of the three viruses mentioned, by virus, region, and age group. Due to budget constraints, RESP-LENS was not funded beyond the end of the 2024 fiscal year. RESP-LENS served as a valuable tool for public health and health care professionals and allowed users to visualize and understand trends in virus circulation, estimate disease burden, respond to outbreaks, and inform decisions and strategies for protecting public health.
Dataset Details
- Publisher: Centers for Disease Control and Prevention
- Temporal Coverage: 2022-23 and 2023-24 respiratory illness seasons (2 October 2022 through 31 August 2024; data from last 5 weeks of 2023-24 season not available)
- Geographic Coverage: 24 sites/health systems with a total of >100 participating hospitals located in 20 states and the District of Columbia
- Last Modified: 2024-12-26
- Contact: RESP-LENS ([email protected])
Source
Original data can be found at: https://data.cdc.gov/d/ch5i-63ve
Usage
You can load this dataset using:
from datasets import load_dataset
dataset = load_dataset('HHS-Official/resp-lens')
License
This dataset is licensed under http://opendefinition.org/licenses/odc-odbl/
- Downloads last month
- 31